<DOC>
	<DOCNO>NCT02892877</DOCNO>
	<brief_summary>The French Gestational Trophoblastic Disease ( GTD ) centre set active registering , monitor treat woman GTD since november 1999 . The aim improve management trophoblastic disease France . About 850 new case register year 140 woman treat , mostly chemotherapy surgery . The center work follow , base multidisciplinary approach . The policy patient remain followed local physician , see treat Center demand registry do voluntary basis . Each administrative french area local expert team ( oncologist gynaecologist ) able look patient help national reference center physician base Lyon . - Once doctor discovers molar pregnancy , contact center , agreement patient , opinion , advice simply report case . - The center send doctor informed consent form sign patient , register form information pathology patient physician , first guideline base initial pathology report . The patient remain followed gynecologist , stay first interlocutor throughout whole process go local laboratory hCG monitoring ; - A letter send initial pathology laboratory originally carry diagnosis molar pregnancy require slide send pathologist referral center ( 9 expert specific pathologist national network ) centrally review initial diagnosis . - In mean time , data manager collect weekly hCG value establish follow-up chart . The physician regularly inform mail hCG evolution . - The local physician contact case modification diagnosis pathologist expert . The center inform length monitoring methodology . - Emails letter send step management ( inclusion , hCG negativation , end hCG follow-up ) . - In case abnormal hCG evolution ( raise , plateauing positivity 6 month , ) neoplasia anatomopathologically diagnose ( choriocarcinoma , PSTT ETT ) , physician immediately contact phone email referent gynaecologist . A complete work include pelvic US Doppler , pelvic MRI , thoraco-abdominal CT-scan chest radiography pulmonary nodule present brain MRI , plan determine adequate treatment . Very briefly , base imaging result , FIGO stade score calculated determine risk . In case low-risk , monochemotherapy settle , polychemotherapy start case high-risk disease . The investigator developped specific expertise key level diagnosis , management , follow-up , fertility preservation treatment . Assignments : - Registration monitoring post diagnosis complete partial molar pregnancy , choriocarcinoma , PSTT , ETT , atypical placental site nodule - Histopathological analysis genetics service - Measurement human chorionic gonadotrophin ( hCG ) isoforms - Complex gynaecological surgery</brief_summary>
	<brief_title>The French National Reference Centre GTD</brief_title>
	<detailed_description />
	<mesh_term>Hydatidiform Mole</mesh_term>
	<mesh_term>Gestational Trophoblastic Disease</mesh_term>
	<mesh_term>Hydatidiform Mole , Invasive</mesh_term>
	<mesh_term>Trophoblastic Neoplasms</mesh_term>
	<criteria>Patients eligible histologically proven trophoblastic disease , diagnosis gestational trophoblastic neoplasia do abnormal evolution hCG</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Complete Hydatidiform mole</keyword>
	<keyword>Partial Hydatidiform mole</keyword>
	<keyword>Invasive mole</keyword>
	<keyword>Choriocarcinoma</keyword>
	<keyword>Post-molar neoplasia</keyword>
	<keyword>Placental Site Trophoblastic Tumor ( PSTT )</keyword>
	<keyword>Epithelioid Trophoblastic Tumor ( ETT )</keyword>
	<keyword>hCG follow-up</keyword>
</DOC>